His termination appears timed to prevent his participation in a meeting today with German vaccine regulators
Two weeks ago, BKK ProVita chairman Andreas Schöfbeck caused a small uproar by writing to Germany’s vaccine regulator, the Paul-Ehrlich-Institut, to inquire about the high rate of vaccine side-effects evident from BKK billing data.
Representatives from the Paul-Ehrlich-Institut, including its president, Klaus Cichutek, had agreed to meet with Schöfbeck and other BKK officials about their concerns this afternoon. Schöfbeck’s termination was obviously timed to prevent his participation at that meeting, which will now go forward without him.
This is the behaviour of people who have deep confidence in the safety and effectiveness of our Corona vaccines.